title: Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
abstract: Serum neutralizing, nasopharyngeal neutralizing, and IgA antibodies were determined in 123 infants immunized with one of four schedules containing live oral vaccine (OPV), inactivated vaccine (IPV), or combinations of the two trivalent poliovirus vaccines: OPV-OPV-OPV, IPV-IPV-IPV, IPV-OPV-OPV, or IPV-IPV-OPV. Nearly 100% of individuals formed serum neutralizing antibodies. The highest geometric mean titer (GMT) of antibody to polioviruses 1, 2, and 3 occurred in groups IPV-IPV-OPV, IPV-OPV-OPV, and IPV-IPV-IPV, respectively. Local neutralizing and IgA antibody responses were detected in 41%-88% and 75%-100%, respectively. Peak GMT of nasopharyngeal antibodies differed minimally between immunization groups. The data suggest that incorporation of at least one dose of IPV at the start of the immunization schedule tends to increase systemic as well as local antibody production.
authors.affiliation: Department of Pediatrics, State University of New York School of Medicine, Buffalo.
authors.forename: H
authors.initials: H
authors.lastname: Faden
authors.forename: J F
authors.initials: JF
authors.lastname: Modlin
authors.forename: M L
authors.initials: ML
authors.lastname: Thoms
authors.forename: A M
authors.initials: AM
authors.lastname: McBean
authors.forename: M B
authors.initials: MB
authors.lastname: Ferdon
authors.forename: P L
authors.initials: PL
authors.lastname: Ogra
mesh_terms: D000914:Antibodies, Viral / Q000096:biosynthesis*; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis*; D007223:Infant; D008297:Male; D009500:Neutralization Tests; D017955:Poliovirus / Q000276:immunology* / Q000302:isolation & purification; D011054:Poliovirus Vaccine, Inactivated / Q000276:immunology*; D011055:Poliovirus Vaccine, Oral / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007070:Immunoglobulin A; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral